Abstract
Chronic lung disease in the extremely preterm baby is still a major complication in neonatal intensive care. Perinatal (ante- and neonatal) glucocorticoids are widely used to prevent severe infant respiratory distress syndrome and/or to reduce chronic lung disease respectively. A review of the literature regarding the cardiovascular side effects of antenatal and neonatal glucocorticoids is presented here.
| Original language | English |
|---|---|
| Pages (from-to) | 190-197 |
| Number of pages | 8 |
| Journal | Current Pediatric Reviews |
| Volume | 3 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Aug 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Betamethasone
- Chronic lung disease
- Hypertrophy
- Protein/DNA ratio
- Respiratory Distress Syndrome
Fingerprint
Dive into the research topics of 'Long-term effects of perinatal glucocorticoid treatment on the heart'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver